SGF Tampa Bay LLC – FDA 483, Feb 24, 2020
SGF Tampa Bay LLC, a reproductive tissue establishment, was cited for multiple deficiencies related to donor screening, record-keeping, and labeling of human cells, tissues, and cellular and tissue-based products (HCT/Ps). The inspection revealed failures in screening donors for communicable disease risks, incomplete records for ineligible donors, and improper labeling of HCT/Ps with biohazard warnings. Additionally, the firm failed to ensure its contract laboratory complied with good tissue practice requirements and maintained legible donor eligibility records.
ID · ecaf4e61-3f29-440a-8e80-f0bf4e539e11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.